Home LiteratureArticle Details
PMID: 3519367 Published · ppublish English Clinical Trial Journal Article Research Support, Non-U.S. Gov't

An interpretation of retinopathy of prematurity in terms of spindle cells: relationship to vitamin E prophylaxis and cryotherapy.

Kretzer FL, McPherson AR, Hittner HM

Abstract

Spindle cells in the hyperoxygenated, avascular, vanguard retina are proposed to be the peripheral inducers of the neovascularization associated with retinopathy of prematurity (ROP). The induction of ROP is conceptualized in terms of three basic events. First, activation of spindle cells results initially in the increase in gap junctions between adjacent spindle cells, secondarily in the increase in cytoplasmic volume of rough endoplasmic reticulum, and ultimately in the synthesis and secretion of angiogenic factors Second, maturation of spindle cells is associated with a decrease in gap junctions, a diminished cytoplasmic volume of rough endoplasmic reticulum, and a cessation of synthesis and secretion of angiogenic factors. Third, myofibroblasts invade the vitreous concomitantly with spindle cell maturation and provide the tractional force that can produce retinal separation. The extent of interstitial retinol binding protein within the subretinal space explains the gestational-age-dependent efficacy of vitamin E in suppressing the development of severe ROP. The kinetics of both spindle cell activation/maturation and myofibroblast invasion predict the efficacy of appropriately timed and placed transretinal cryotherapy.

MeSH Terms
Cell Movement Clinical Trials as Topic Cryosurgery Endoplasmic Reticulum/ultrastructure Fibroblasts/pathology Humans Infant, Newborn Intercellular Junctions/ultrastructure Photoreceptor Cells/growth & development Retinol-Binding Proteins/metabolism Retinopathy of Prematurity/pathology,prevention & control,surgery Vitamin E/therapeutic use
Chemicals
Retinol-Binding Proteins Vitamin E
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Kretzer F L
McPherson A R
Hittner H M
References (34)
34 references, click to expand
  1. Retrolental fibroplasia and vitamin E in the preterm infant--comparison of oral versus intramuscular:oral administration.
    Pediatrics. 1984 Feb;73(2):238-49 PMID: 6546416
  2. In situ actin distribution in excised retrolental membranes in retinopathy of prematurity.
    Arch Ophthalmol. 1985 Oct;103(10):1553-6 PMID: 3840367
  3. Vitamin E and retrolental fibroplasia. Improved visual outcome with early vitamin E.
    Ophthalmology. 1983 May;90(5):428-35 PMID: 6348635
  4. Retinal hemorrhage in retinopathy of prematurity associated with tocopherol treatment.
    Ophthalmology. 1985 Aug;92(8):1012-4 PMID: 3900847
  5. Development of the subretinal space in the preterm human eye: ultrastructural and immunocytochemical studies.
    J Comp Neurol. 1985 Mar 22;233(4):497-505 PMID: 3884672
  6. The premature infant, vitamin E deficiency and retrolental fibroplasia.
    Am J Clin Nutr. 1974 Oct;27(10):1158-73 PMID: 4608928
  7. Vitamin E protects against retinopathy of prematurity through action on spindle cells.
    Nature. 1984 Jun 28-Jul 4;309(5971):793-5 PMID: 6738695
  8. Vitamin E supplementation and the retinopathy of prematurity.
    Ann N Y Acad Sci. 1982;393:473-95 PMID: 6756262
  9. The treatment of advanced retinopathy of prematurity by cryotherapy and scleral buckling surgery.
    Ophthalmology. 1985 Mar;92(3):379-87 PMID: 2581207
  10. Retrolental fibroplasia: further clinical evidence and ultrastructural support for efficacy of vitamin E in the preterm infant.
    Pediatrics. 1983 Mar;71(3):423-32 PMID: 6687494
  11. Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants.
    N Engl J Med. 1981 Dec 3;305(23):1365-71 PMID: 7029275
  12. The incidence and the results of active treatment of acute retrolental fibroplasia.
    Aust J Ophthalmol. 1982 May;10(2):135-40 PMID: 6896641
  13. Visual outcome and effect of treatment in stage III developing retrolental fibroplasia.
    Br J Ophthalmol. 1982 Jul;66(7):446-9 PMID: 6896458
  14. Cryotherapy for retinopathy of prematurity to prevent retrolental fibroplasia.
    Can J Ophthalmol. 1982 Oct;17(5):207-12 PMID: 6184144
  15. Management of retinopathy of prematurity.
    Ophthalmology. 1985 Aug;92(8):995-9 PMID: 3840245
  16. Muscular calcification following injection of vitamin E in newborn infants.
    Eur J Pediatr. 1984 Jun;142(2):145-6 PMID: 6468435
  17. Acute retrolental fibroplasia. II. Treatment by cryosurgery.
    Arch Ophthalmol. 1978 Nov;96(11):2049-53 PMID: 581468
  18. Treatment of acute proliferative retrolental fibroplasia.
    Trans Am Acad Ophthalmol Otolaryngol. 1972 Sep-Oct;76(5):1234-46 PMID: 4679275
  19. Demonstration of vasoproliferative activity from mammalian retina.
    J Cell Biol. 1980 Feb;84(2):298-304 PMID: 6155381
  20. Cryotherapy for retinopathy of prematurity. A personal retrospective.
    Ophthalmology. 1985 Mar;92(3):375-8 PMID: 2581206
  21. Treatment of acute retrolental fibroplasia by cryopexy.
    Br J Ophthalmol. 1980 Oct;64(10):758-62 PMID: 6893553
  22. The clinical course of retrolental fibroplasia in premature infants.
    South Med J. 1972 Jun;65(6):655-8 PMID: 5067717
  23. Vitamin E and retrolental fibroplasia: ultrastructural support of clinical efficacy.
    Ann N Y Acad Sci. 1982;393:145-66 PMID: 6959556
  24. A clinicopathological case of retinopathy of prematurity (ROP) treated by peripheral cryopexy.
    Br J Ophthalmol. 1984 Jan;68(1):36-41 PMID: 6546294
  25. Pathogenic mechanism of retinopathy of prematurity: a controversial explanation for the efficacy of oral and intramuscular vitamin E supplementation and cryotherapy.
    Bull N Y Acad Med. 1985 Dec;61(10):883-900 PMID: 3866628
  26. Vasculopathic hepatotoxicity associated with E-Ferol syndrome in low-birth-weight infants.
    JAMA. 1985 Nov 1;254(17 ):2422-30 PMID: 3930760
  27. Relationship of prolonged pharmacologic serum levels of vitamin E to incidence of sepsis and necrotizing enterocolitis in infants with birth weight 1,500 grams or less.
    Pediatrics. 1985 Apr;75(4):619-38 PMID: 3885152
  28. Vitamin E and retinopathy of prematurity. Follow-up at one year.
    Ophthalmology. 1985 Aug;92(8):1005-11 PMID: 3900846
  29. Influence on retrolental fibroplasia of intramuscular vitamin E administration during respiratory distress syndrome.
    Ophthalmology. 1982 Feb;89(2):96-103 PMID: 7041039
  30. Effect of intramuscular vitamin E on frequency and severity of retrolental fibroplasia. A controlled trial.
    Lancet. 1982 May 15;1(8281):1087-91 PMID: 6122890
  31. Prevention of cicatricial retrolental fibroplasia by cryotherapy.
    Can J Ophthalmol. 1978 Oct;13(4):277-82 PMID: 581747
  32. Unusual syndrome among premature infants: association with a new intravenous vitamin E product.
    Pediatrics. 1985 Mar;75(3):598-602 PMID: 3975131
  33. Cryotherapy for retinopathy of prematurity.
    Ophthalmology. 1980 Nov;87(11):1121-7 PMID: 6165948
  34. Vitamin E in retrolental fibroplasia.
    N Engl J Med. 1983 Sep 15;309(11):669-70 PMID: 6688460
Article Info
Journal
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Abbr.
Graefes Arch Clin Exp Ophthalmol
ISSN
0721-832X
Published
1986-00-00
Pages
205-14
Language
English
Region
Germany
NLM ID
8205248
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]